Researchers and clinicians convened to establish a clinical roadmap for senescence research, identifying priorities including functional classification of senescent states, standardized biomarkers, and precision medicine frameworks. This represents the first coordinated effort to bridge cellular senescence findings into clinical practice and policy.
Key Points
- Senescent states require functional classification systems for clinical application
- Standardized, actionable biomarkers are essential for precision senescence medicine
- Translational frameworks and international collaboration needed to move research to practice
Longevity Analysis
Cellular senescence—the accumulation of non-functional cells that contribute to tissue degradation and systemic dysfunction—represents a primary driver of age-related decline across multiple organ systems. The establishment of functional classification and biomarker standardization addresses a critical gap: clinicians currently lack reliable tools to identify and measure senescent burden in living patients. Without this foundational infrastructure, interventions targeting senescence (whether pharmacological, behavioral, or regenerative) cannot be monitored, compared, or refined. This roadmap creates the prerequisite conditions for moving senescence science from research validation into clinical decision-making—a shift that fundamentally changes how practitioners approach tissue regeneration, defense against age-related disease, and sustained cellular integrity.
Original published by Nature Aging, by Aniello Cerrato.